NDC product
Nicotine Transdermal System
NDC 3215-1203 · Aveva Drug Delivery Systems Inc.
Key facts
| Product NDC | 3215-1203 |
|---|---|
| Proprietary name | Nicotine Transdermal System |
| Nonproprietary name | Nicotine Transdermal System |
| Substances | NICOTINE |
| Dosage form | PATCH |
| Route | TRANSDERMAL |
| Labeler | Aveva Drug Delivery Systems Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA074612 |
| Pharmacologic classes | Cholinergic Nicotinic Agonist [EPC], Nicotine [CS] |
| Marketing start | Jun 25, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: